in this issue
Sentinel lymph node biopsy for staging early breast cancer : minimizing the trade-off by maximizing the accuracy
High-resolution lymphoscintigraphy is essential for recognition of the significance of internal mammary nodes in breast cancer
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases : recommendations from an expert panel
Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer
Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes : results of randomized trial
Unavoidable mastectomy for ipsilateral breast tumour recurrence after conservative surgery : patient outcome
Chemokine receptors in advanced breast cancer : differential expression in metastatic disease sites with diagnostic and therapeutic implications
Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer
Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens
Prognostic significance of histological grade in clear-cell carcinoma of the ovary : a retrospective study of Korean Gynecologic Oncology Group
The prognostic value of DNA ploidy in a total population of uterine sarcomas
Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study
DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer
Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer
Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer : a multi-institutional phase II study
A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC)
A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma : results of Cancer and Leukemia Group B (CALGB) 90102
Hepatosplenic gamma-delta T-cell lymphoma : clinicopathological features and treatment
Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type
The regulatory BCL2 promoter polymorphism (−938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma
Prediction of fatal intracranial hemorrhage in patients with acute myeloid leukemia
A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin α : a prospective randomized controlled trial of the ELYPSE study group
Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172 210 men and women : a prospective 19-year follow-up study
Cancer risk in hospitalized sarcoidosis patients : a follow-up study in Sweden
Soft tissue sarcomas of the trunk wall (STS-TW) : a study of 343 patients from the French Sarcoma Group (FSG) database
Osteosarcoma in adolescents and adults : survival analysis with and without lung metastases
An unusual BRCA2 allele carrying two splice site mutations
‘Sunitinib withdrawal phenomenon’ or spontaneous regression in renal cell cancer
Comment on ‘Older cancer patients in an Italian hospice’
Experience with 90Y-ibritumomab tiuxetan for relapsed classical Hodgkin lymphoma
Classification of biliary tract cancer (BTC) : evaluation of all entities
Classification of biliary tract cancer (BTC) : evaluation of all entities
FDG–PET : for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer?
FDG–PET : for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer?